|
|
Reference
|
|
 
|
Aurigemma, G.P., Gaasch, W.H. (2004) Diastolic Heart Failure. N Eng J Med, 351(11): 1
|
|
2 
|
Bie, M.K., Dam, B., Gaasbeek, A., Buren, M., Erven, L., Bax, J.J., Schalij, M.J., Rabelink, T.J., Jukema, W.J. (2009) The current status of interventions aiming at reducing sudden cardiac death in dialysis patients. Eur Heart J, 30(13): 1559-64
|
|
1 
|
Chan, C.T., Levin, N.W., Chertow, G.M., Larive, B., Schulman, G., Kotanko, P. (2010) Determinants of cardiac autonomic dysfunction in ESRD. Clin J Am Soc Nephrol, 5(10): 1821-7
|
|
3
|
Cice, G., Ferrara, L., di Benedetto, A., Russo, P.E., Marinelli, G., Pavese, F., Iacono, A. (2001) Dilated cardiomyopathy in dialysis patients: beneficial effects of carvedilol: a double-blind, placebo-controlled trial. J Am Coll Cardiol, 37(2): 407-11
|
|
2
|
Cice, G., Ferrara, L., Andrea, A.D., Isa, S.D., di Benedetto, A., Cittadini, A., Russo, P.E., Golino, P., Calabrò, R. (2003) Carvedilol increases two-year survivalin dialysis patients with dilated cardiomyopathy: a prospective, placebo-controlled trial. J Am Coll Cardiol, 41(9): 1438-44
|
|
3
|
Cohen-Solal, A. (1998) Left ventricular diastolic dysfunction: pathophysiology, diagnosis and treatment. Nephrol Dial Transplant, 13(suppl 4)
|
|
2
|
David, S., Kümpers, P., Seidler, V., Biertz, F., Haller, H., Fliser, D. (2008) Diagnostic value of N-terminal pro-B-type natriuretic peptide (NT-proBNP) for left ventricular dysfunction in patients with chronic kidney disease stage 5 on haemodialysis. Nephrol Dial Transplant, 23(4): 1370-7
|
|
|
de Bie, M.K., Buiten, M.S., Rabelink, T.J., Jukema, W.J. (2012) How to reduce sudden cardiac death in patients with renal failure. Heart, 98(4): 335-41
|
|
2
|
Flythe, J.E., Brunelli, S.M. (2011) The risks of high ultrafiltration rate in chronic hemodialysis: implications for patient care. Semin Dial, 24(3): 259-65
|
|
|
Furgeson, S.B., Chonchol, M. (2008) Beta-blockade in chronic dialysis patients. Semin Dial, 21(1): 43-8
|
|
|
Green, D., Roberts, P.R., New, D.I., Kalra, P.A. (2011) Sudden Cardiac Death in Hemodialysis Patients: An In-Depth Review. Am J Kidney Dis, 57(6): 921
|
|
|
Gussak, I., Gussak, H.M. (2007) Sudden cardiac death in nephrology: focus on acquired long QT syndrome. Nephrol Dial Transplant, 22(1): 12-4
|
|
1
|
Hamlin, S.K., Villars, P.S., Kanusky, J.T., Shaw, A.D. (2004) Role of diastole in left ventricular function, II: diagnosis and treatment. Am J Crit Care, 13(6): 453-66; quiz 467-8
|
|
1
|
Herzog, C.A. (2007) Can we prevent sudden cardiac death in dialysis patients?. Clin J Am Soc Nephrol, 2(3): 410-2
|
|
|
Herzog, C.A., Mangrum, M.J., Passman, R. (2008) Sudden cardiac death and dialysis patients. Semin Dial, 21(4): 300-7
|
|
|
Ie, E.H.Y., Zietse, R. (2006) Evaluation of cardiac function in the dialysis patient: a primer for the non-expert. Nephrol Dial Transplant, 21(6): 1474-81
|
|
|
Ito, I., Kono, K., Shinbo, G., Tadokoro, K., Abe, C., Takemura, N., i dr. (2009) Implantable cardioverter defibrillator in maintenance hemodialysis patients with ventricular tachyarrhythmias: A single-center experience. Hemodialysis Int, 13(1): 48
|
|
1
|
Johnston, N., Dargie, H., Jardine, A. (2008) Diagnosis and treatment of coronary artery disease in patients with chronic kidney disease: Ischaemic heart disease. Heart, 94(8): 1080-8
|
|
2
|
Kanbay, M., Solak, Y., Covic, A., Goldsmith, D. (2011) Sudden cardiac death in patients with chronic kidney disease: prevention is the sine qua non. Kidney Blood Press Res, 34(4): 269-76
|
|
2
|
Kanbay, M., Afsar, B., Goldsmith, D., Covic, A. (2010) Sudden death in hemodialysis: an update. Blood Purif, 30(2): 135-45
|
|
1
|
Korantzopoulos, P., Liu, T., Li, L., Goudevenos, J.A., Li, G. (2009) Implantable cardioverter defibrillator therapy in chronic kidney disease: a meta-analysis. Europace, 11(11): 1469-75
|
|
8
|
London, G.M., Guerin, A.P., Marchais, S.J. (1999) Hemodynamic Overload in End-Stage Renal Disease Patients. Semin Dial, 12(2): 77
|
|
|
London, G.M. (2003) Cardiovascular disease in chronic renal failure: pathophysiologic aspects. Semin Dial, 16(2): 85-94
|
|
|
Maisel, A.S., Katz, N., Hillege, H.L., Shaw, A., Zanco, P., Bellomo, R., Anand, I., Anker, S.D., Aspromonte, N., Bagshaw, S.M., Berl, T., Bobek, I. (2011) Biomarkers in kidney and heart disease. Nephrol Dial Transplant, 26(1): 62-74
|
|
5
|
Massy, Z.A., Kasiske, B.L. (2000) Prevention of cardiovascular complications in chronic renal disease. u: Loscalzo J., London G.M. [ur.] Cardiovascular Disease in End-stage Renal Failure, New York: The Oxford University Press, : 463-81
|
|
1
|
McCullough, P.A., Sandberg, K.R. (2004) Chronic kidney disease and sudden death: strategies for prevention. Blood Purif, 22(1): 136-42
|
|
|
McMahon, L.P., Roger, S.D., Levin, A. (2004) Development, prevention, and potential reversal of left ventricular hypertrophy in chronic kidney disease. J Am Soc Nephrol, 15(6): 1640-7
|
|
|
McQuillan, R.F., Chan, C.T. (2012) The intuitive case for β-blockers in patients with ESRD. Semin Dial, 25(1): 15-21
|
|
12
|
Middleton, R.J., Parfrey, P.S., Foley, R.N. (2001) Left ventricular hypertrophy in the renal patient. J Am Soc Nephrol, 12(5): 1079-84
|
|
12
|
Middleton, R.J., Parfrey, P.S., Foley, R.N. (2001) Left Ventricular Hypertrophy in the Renal Patient. J Am Soc Nephrol, 12(5): 107
|
|
1
|
Nevis, I.F., Mathew, A., Novick, R.J., Parikh, C.R., Devereaux, P.J., Natarajan, M.K., Iansavichus, A.V., Cuerden, M.S., Garg, A.X. (2009) Optimal method of coronary revascularization in patients receiving dialysis: systematic review. Clin J Am Soc Nephrol, 4(2): 369-78
|
|
|
Parfrey, P.S., Collingwood, P., Foley, R.N., Bährle, A. (1996) Images in nephrology. Left ventricular disorders detected by M-mode echocardiography in chronic uraemia. Nephrol Dial Transplant, 11(7): 1328-31
|
|
14
|
Parfrey, P.S. (2000) Cardiac disease in dialysis patients: diagnosis, burden of disease, prognosis, risk factors and management. Nephrol Dial Transplant, 15(suppl 5)
|
|
2
|
Pecoits-Filho, R., Bucharles, S., Barberato, S.H. (2012) Diastolic heart failure in dialysis patients: mechanisms, diagnostic approach, and treatment. Semin Dial, 25(1): 35-41
|
|
|
Petrović, D. (2012) Srčana slabost kod bolesnika na hemodijalizi. u: Petrović D. [ur.] Kardiovaskularne bolesti kod bolesnika na hemodijalizi, Kragujevac: Medicinski fakultet i Inter Print, : 271-88
|
|
2 
|
Petrović, D., Tirmenštajn-Janković, B., Živanović, M., Nikolić, A., Poskurica, M., Stojimirović, B. (2010) Iznenadna srčana smrt kod bolesnika koji se leče redovnim hemodijalizama. Timočki medicinski glasnik, vol. 35, br. 1-2, str. 19-26
|
|
|
Petrović, D., Obrenović, R., Stojimirović, B. (2008) Cardiac troponins and left ventricular hypertrophy in hemodialysis patients. Clin Lab, 54(5-6): 145-52
|
|
|
Petrović, D., Jagić, N., Miloradović, V., Stojimirović, B. (2008) Clinical importance of biochemical markers of cardiac damage in hemodialysis patients. Serbian Journal of Experimental and Clinical Research, vol. 9, br. 1, str. 19-25
|
|
3
|
Petrović, D., Stojimirović, B.B. (2009) Cardiac troponins: outcome predictors in hemodialysis patients. J Artif Organs, 12(4): 258-63
|
|
2
|
Petrović, D., Miloradović, V., Poskurica, M., Stojimirović, B. (2011) Heart failure in haemodialysis patients: Evaluation and treatment. Srpski arhiv za celokupno lekarstvo, vol. 139, br. 3-4, str. 248-255
|
|
6
|
Petrović, D., Stojimirović, B. (2008) Hipertrofija leve komore kod bolesnika koji se leče redovnim hemodijalizama. Medicinski pregled, vol. 61, br. 7-8, str. 369-374
|
|
8
|
Petrović, D., Stojimirović, B. (2007) Protok krvi kroz vaskularni pristup za hemodijalizu - faktor rizika za razvoj kardiovaskularnih komplikacija kod bolesnika na hemodijalizi. Medicinski pregled, vol. 60, br. 3-4, str. 183-186
|
|
|
Petrović, D., Poskurica, M., Stojimirović, B. (2011) Hipertrofija leve komore kod bolesnika na hemodijalizi - faktori rizika i lečenje. Medicinska istraživanja, vol. 45, br. 3, str. 30-35
|
|
2
|
Petrović, D., Jagić, N., Miloradović, V., Nikolić, A., Stojimirović, B. (2011) Diagnostics and therapy of left ventricular hypertrophy in haemodialysis patients. Serbian Journal of Experimental and Clinical Research, vol. 12, br. 1, str. 37-40
|
|
1
|
Postorino, M., Marino, C., Tripepi, G., Zoccali, C. (2007) Prognostic value of the New York Heart Association classification in end-stage renal disease. Nephrol Dial Transplant, 22(5): 1377-82
|
|
2
|
Ranpuria, R., Hall, M., Chan, C.T., Unruh, M. (2008) Heart rate variability (HRV) in kidney failure: measurement and consequences of reduced HRV. Nephrol Dial Transplant, 23(2): 444-9
|
|
12
|
Rigatto, C., Parfrey, P.S. (2001) Uraemic Cardiomyopathy: an Overload Cardiomyopathy. J Clin Basic Cardiol, 4(2): 93-9
|
|
|
Roberts, J.K., Patel, U.D. (2011) Management of coronary artery disease in end-stage renal disease. Semin Dial, 24(5): 525-32
|
|
1
|
Roberts, P.R., Green, D. (2011) Arrhythmias in chronic kidney disease. Heart, 97(9): 766-73
|
|
1
|
Shamseddin, K.M., Parfrey, P.S. (2011) Sudden cardiac death in chronic kidney disease: epidemiology and prevention. Nat Rev Nephrol, 7(3): 145-54
|
|
7
|
Sood, M.M., Pauly, R.P., Rigatto, C., Komenda, P. (2008) Left ventricular dysfunction in the haemodialysis population. NDT Plus, 1(4): 199-205
|
|
|
Stojimirović, B., Petrović, D., Obrenović, R. (2007) Hipertrofija leve komore kod bolesnika na hemodijalizi: značaj anemije. Med Pregl, 60(suppl 2)
|
|
|
Wang, A.Y., Sanderson, J.E. (2011) Current perspectives on diagnosis of heart failure in long-term dialysis patients. Am J Kidney Dis, 57(2): 308-19
|
|
|
Williams, M.E. (2006) Coronary revascularization in diabetic chronic kidney disease/end-stage renal disease: a nephrologist's perspective. Clin J Am Soc Nephrol, 1(2): 209-20
|
|
|
Wu, V., Lin, L., Wu, K. (2005) QT interval dispersion in dialysis patients. Nephrology (Carlton), 10(2): 109-12
|
|
|
|
|